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Abstract. We describe here research directed towards early (presyndromic) 
diagnosis of infection. By using a mouse model and a multi-component blood 
protein diagnostic tool we detected cowpox infection several days in advance of 
overt symptoms with high accuracy. We provide details of the experimental design 
and measurement technique and elaborate on the long-range implication of these 
results.
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1. Introduction
There is growing urgency to develop techniques for rapid detection and diagnosis 
of infectious disease in human populations. Rapid detection is critical for reducing the 
morbidity and mortality from either bio-terrorism events or newly emerging diseases. 
Current methods for direct agent detection using culture methods or microbial 
component detection using antibodies or PCR have a number of limitations. Rapid 
microbial detection in blood may not be possible for agents that remain localized to the 
site of infection or agents that do not appear in peripheral blood until the later stages of 
the disease. Cell culture and sample enrichment procedures can also require several 
days. Finally, newly emerging diseases or genetically modified organisms may have 
never been seen before complicating organism-specific detection methods.
Host responses may provide early signals in blood even from localized infections. 
Cells in the innate immune system produce a rapid response after initial contact with a 
potential pathogen. While pathogen responses initially involve local cell signaling 
processes designed to activate near-by immune cells, cascades of cytokines and 
chemokines are released into the periphery to activate additional cells types and to 
cause them to migrate to the site of the infection. Thus, early immune responses may 
provide general indicators for the presence of many different infection types. A 
spectrum of innate and adaptive immune markers, in combination with other 
biochemical markers comprise a ‘signature’ that may allow for timely, disease-specific 
detection.
Direct studies of the time course of natural diseases in humans is complicated by 
the difficulty in defining exposure doses and exposure timing. Model systems, both in 
cell culture and animal models, allow precise control over exposure dose and timing. 
Studies of specific tissue types in culture have been used to define early responses in 
cells at the to pathogen exposure, but it is often difficult to relate these tissue-specific 
responses to systemic responses in the whole animal. Consequently, we chose cowpox 
infection in mice as the model system for studies of early disease detection through 
blood protein signatures. Mice have been shown to be susceptible to infection by both 
cowpox and vaccinia viruses [1, 2]. The severity of infection varies from mild to lethal 
depending on the strain of mouse, strain of virus, and the location and dose of viral 
challenge. Viral instillation in the lung of mice produces a pulmonary infection that has 
been used as a model for pulmonary smallpox infection in humans, so that this model 
has been used extensively for studies of anti-viral drugs [3, 4]. 
The TK- strain of cowpox virus into BALB/c mice model used for these studies 
exhibits three major features important to early detection of infections. First, there is an 
incubation period of about 6 days before the mice show signs of illness. This provides 
the opportunity to assess protein changes in serum throughout this prodromal period, as 
well as the period of active infection. Second, this model produces a localized infection 
in the lung, with no live virus detectable in the blood using plate assays. Thus, this 
model is well suited to analyze whole-animal systemic responses in blood to a localized 
infection. Finally, the conditions used for these studies produce a serious illness, but no 
lethality was observed from viral infection. This feature allows assessment of the early 
stages of recovery from infection, and insures that the biochemical changes we observe 
reflect moderate disease rather than the severe toxicity of super-lethal doses. 
In ths paper we describe the use of canonical variate analysis (CVA) to predict pre-
symptomatic illness in mice inoculated with cowpox virus. Signatures were developed 
from measurements of specific blood serum protein concentrations determined by 
Rules Based Medicine, Inc., Austin, TX using Luminex Liquid Array LA technology. 
We applied CVA to training sets of data to find transformations to the canonical space 
specifying the optimal group separation. These transformations were then applied to 
test sets to determine where individual mice mapped to in canonical space. Group 
membership of each individual was predicted by assigning membership to the training 
group lying closest to the individual in canonical space. Finally, assigned membership 
was compared with known true membership and the results expressed as a confusion 
matrix.
We have made three separate analyses and have recommendations for follow on 
analyses based on the results for the two experiments analyzed here.
2. Experiments
All experimental work with the mice was performed in a biosafety level 3 (BSL-3) 
animal facility at the University of New Mexico [5, 6]. Mice were infected with CPV 
by surgical intratracheal instillation. The infected mouse group received 50 ul of media 
(PBS 2.5% BGS diluted 1:2 in Tris buffer) containing CPV. The sham group received 
the same intratracheal surgical procedure with 50ul of media only. The naïve control 
group received no surgery or CPV.
Animals were sacrificed at each experimental time point to obtain serum samples. 
The animals were euthanized via Avertin overdose. Blood was collected from clipped 
vena cava and placed in eppendorf tube. The blood was allowed to coagulate for at 
least 30 minutes at 4°C. The whole blood was then centrifuged at 4500 RPM for 10 min 
in microfuge, and the serum from each mouse was placed in individual eppendorf 
tubes. The samples were stored at -80°C and analyzed at the end of the study. Serum 
volumes varied from 700 to 200 microliters, with lower recoveries at the peak of the 
disease.
The two experiments analyzed herein were conducted a month apart in spring-
summer of 2005. In each experiment 60 mice were given tracheotomies. In 30 of these 
mice, cowpox virus (CPV) was injected in the tracheotomies. In the other 30 mice, 
saline solutions were injected (sham). On days 2, 3, 4, 5, 6, and 8, five CPV and five 
sham mice were sacrificed and blood collected from the chest cavities. Mouse serum 
samples were transported frozen on dry ice to Rules Based Medicine (RBM) for 
multiplex immunoassay analysis (Rules Based Medicine, Inc., Austin, TX). RBM 
utilizes a multi-analyte panel to quantify the concentrations of about 60 host antigens in 
mouse serum samples. A total of 50 microliters of serum were shipped for each 
analysis, with all serum samples coded for blind analysis. While some aspects of this 
multiplex analysis are proprietary, the following briefly describes the approach. Sample 
is incubated with a mixture of fluorescently labeled microsphere types, with each bead 
type conjugated to a different capture antibody. A mixture of biotinylated secondary 
antibodies is then added to label bead-captured antigen. Finally streptavidin-
phycoerythrin is added to fluorescently label the captured antigen. Flow cytometric 
analysis with a Luminex 100 flow analyzer is used to quantify fluorescence signals for 
ach antigen in the analysis. Purified antigen standards are included is some samples to 
develop standard curves for relating bead-based fluorescence to antigen concentration. 
Sample processing typically requires 1 to 3 hours, and flow cytometric analysis takes 
about 1 minute per sample [7, 8, 9]. Additional details of the RBM analysis can be 
found at www.rulesbasedmedicine.com . 
Assay results are reported in units of protein concentration. A “Lowest Detectable 
Dose” (LDD) is also reported for each antigen. The LDD is the antigen concentration 
that produces a fluorescence signal that is 3 standard deviations above the fluorescence 
of negative control beads. Table 1 below lists the 54 protein for which we had assays, 
of these we used 43 proteins in the analysis described herein. These 43 proteins are the 
ones for which at least two mice had levels above the LDD in both experiments. 
Protein concentration values were set to 0.5*LLD for assay results that were below the 
LDD for the protein. 
Animals were monitored for behavioral signs of illness including ruffled fur and 
decreased activity. While a few animals began to show symptoms on day 5, most 
animals showed clear signs of illness on days 6 and 8.
Table 1. Proteins measured in the RBM panel used for experiments 1 and 2.
Apo A1 (Apolipoprotein A1) IL-1alpha (Interleukin-1alpha) MDC (Macrophage-Derived Chemokine)
CRP (C Reactive Protein) IL-1beta (Interleukin-1beta) MIP-1alpha (Macrophage Inflammatory Protein-1alpha)
EGF (Epidermal Growth Factor) IL-2 (Interleukin-2) MIP-1beta (Macrophage Inflammatory Protein-1beta)
Endothelin-1 IL-3 (Interleukin-3) MIP-1gamma (Macrophage Inflammatory Protein-1gamma)
Eotaxin IL-4 (Interleukin-4) MIP-2 (Macrophage Inflammatory Protein-2)
Factor VII IL-5 (Interleukin-5) MIP-3beta (Macrophage Inflammatory Protein-3beta)
FGF-9 (Fibroblast Growth 
Factor-9) IL-6 (Interleukin-6) Myoglobin
FGF-basic (Fibroblast Growth 
Factor-basic) IL-7 (Interleukin-7) OSM (Oncostatin M)
GCP-2 (Granulocyte 
Chemotactic Protein-2) Insulin
RANTES (Regulation Upon 
Activation, Normal T-Cell 




IP-10 (Inducible Protein-10) SCF (Stem Cell Factor)
Haptoglobin
KC/GROalpha (Melanoma 




IFN-gamma (Interferon-gamma) Leptin TIMP-1 (Tissue Inhibitor of Metalloproteinase Type-1)
IgA (Immunoglobulin A) LIF (Leukemia Inhibitory Factor) Tissue Factor
IL-10 (Interleukin-10) Lymphotactin TNF-alpha (Tumor Necrosis Factor-alpha)
IL-11 (Interleukin-11) MCP-1 (Monocyte Chemoattractant Protein-1) TPO (Thrombopoietin)
IL-12p70 (Interleukin-12p70) MCP-3 (Monocyte Chemoattractant Protein-3) 
VCAM-1 (Vascular Cell 
Adhesion Molecule-1)
IL-17 (Interleukin-17) MCP-5 (Monocyte Chemoattractant Protein-5)
VEGF (Vascular Endothelial 
Cell Growth Factor)
IL-18 (Interleukin-18) M-CSF (Macrophage-Colony Stimulating Factor) vWF (von Willebrand Factor)
3. Data Analysis
To analyze the training sets we used standard CVA as discussed in Krzanowski 
and Srivatava [10, 11]. These analyses were done in a backward elimination selection 
method, which proceeds using the test on the change in Wilks ratio for each elimination 
as proposed by Rao [12] and described in detail by Hawkins and McHenry [13, 14]. 
See detail on signature development and class prediction in Appendix I.
The data was analyzed by considering the CPV mice sacrificed on days 2 and 3 as 
one group, the CPV mice for days 4 and 5 as another group, the CPV mice for days 6 
and 8 as a third group, the sham mice for days 2 and 3 as a fourth group, the sham mice 
for days 4 and 5 as the fifth group, and the sham mice for days 6 and 8 as the sixth 
group. After the training set is analyzed to find the positions of the training mice (and 
groups) in canonical space, the “unknown” individuals from training set are then 
assigned to one of these six groups by mapping them to canonical space and finding the 
nearest training group for each test individual.
We have made three separate analyses. First we used experiment 1 (the first 
experiment performed) as a training set and experiment 2 as the test set. Second we 
used experiment 2 as the training set and experiment 1 as the test set. Third we made a 
10-fold external cross validation on both experiments. In this cross validation method, 
we combine both experiments into one data set. Thus there will be the same six groups 
but each group will have twenty members instead of the ten when the experiments are 
considered separately. Then the combined data set is repeatedly reanalyzed by random 
partitioning followed by training and testing. This method provides an estimate of the 
overall error rate in predicting class membership. In our case assigning class 
membership is equivalent to deciding whether or not an individual mouse is infected 
with CPV and how much time has elapsed since the infection (or tracheotomy in the 
case of sham mice). 
Details on the class prediction and cross validation techniques are given in 
Appendix I and II.
4. Results
Training Set: = Experiment 1 / Test Set = Experiment 2
In this analysis we found that eight proteins significantly separated the six groups 
in the training set. The proteins were: 





The canonical transformations were constructed from the concentrations of these 
eight proteins.
In Table 2 we show the confusion matrix for using experiment 1 as the training set 
and using experiment 2 as the test set. To read the table read each row from left to 
right. We see immediately that while pox mice for days 4-5 and days 6-8 were well 
predicted to be the appropriate pox group, sham mice were overwhelmingly predicted 
to be pox mice. This level of false positives renders this particular transformation 
useless. The variables (proteins) that separated the groups in experiment 1 were 
peculiar to experiment 1, possibly due to some irreproducible idiosyncrasy of the 
conditions under which experiment 1 was conducted.
Table 2. Confusion matrix for training CVA using experiment 1. Group assignments made on 
experiment 2. Column labeled by “Total” contains the number of mice in groups labeled in 
column one labeled by “Group”












2-3 days 10 0 0 0 4 6 0
Sham 
4-5 days 10 0 0 0 1 9 0
Sham 
6-8 days 10 0 0 3 1 5 1
Pox 
2-3 days 10 0 0 0 4 6 0
Pox 
4-5 days 10 0 0 0 0 9 1
Pox 
6-8 days 10 0 0 0 0 1 9
Training Set = Experiment 2 / Test Set = Experiment 1
In this analysis we found that eight proteins significantly separated the six groups 
in the training set. The proteins were: 





The canonical transformations were constructed from the concentrations of these 
eight proteins. Note that there is some overlap with the proteins chosen in the first 
training analysis. There is also some discrepancy between the two sets.
In Table 3 we show the confusion matrix for using experiment 2 as the training set 
and using experiment 1 as the test set. To read the table read each row from left to 
right. We see immediately that sham mice are overwhelmingly mapped to sham mice. 
We see that pox mice in the 4-5 day group are mainly mapped to the correct pox group 
and pox mice in the 6-8 day groups are mainly mapped to pox mice. We did not do well 
predicting the exact group for 2-3 day pox mice. 
Table 3. Confusion matrix for training CVA using experiment 2. Group assignments made on 
experiment 1. Column labeled by “Total” contains the number of mice in groups labeled in 
column one labeled by “Group”.












2-3 days 10 5 3 0 2 0 0
Sham 
4-5 days 10 2 1 3 4 0 0
Sham 
6-8 days 10 2 5 3 0 0 0
Pox 
2-3 days 10 2 1 0 7 0 0
Pox 
4-5 days 10 0 0 1 1 8 0
Pox 
6-8 days 10 0 0 0 2 0 8
We regard the above results as extremely promising as most pox mice in the 4-5 
day group are correctly mapped, even though most animals show no signs of illness at 
this time period.
Cross Validation
In the 10-fold external cross validation we found that seventeen proteins were 
selected as significantly separating the six groups. 
In Table 4 we show the confusion matrix for the cross validation. Shams are 
mapped mainly to shams. We see that pox mice in the 4-5 day group and in the 6-8 day 
group are mainly mapped to the correct group of pox mice. We did not do well 
predicting the exact group for 2-3 day pox mice. Many 2-3 day pox mice are mapped to 
2-3 day sham mice. While most pre-symptomatic animals at 4-5 days can be correctly 
classified using these 17 proteins, protein alterations at 2-3 days may be too small to 
differentiate pox from sham animals.
These results show promise for disease detection when one considers that which 
sham-group a sham mouse belongs to is of little concern as long as we know it is a 
sham mouse. However which groups a pox mouse belongs to is of concern because of 
treatment options (in other diseases) or public health considerations.
Table 4. Cross validation confusion matrix












2-3 days 20000 12639 2087 1398 3245 631 0
Sham 
4-5 days 20000 2974 9658 6534 833 1 0
Sham 
6-8 days 20000 332 8161 10185 771 0 551
Pox 
2-3 days 20000 6462 155 93 13289 0 1
Pox 
4-5 days 20000 161 123 124 1762 17597 233
Pox 
6-8 days 20000 17 1 0 1746 144 18092
5. Conclusion
In spite of the aggressively invasive nature of the inoculation, we were able to see 
the pattern of expressed proteins relax to normal then signal an alert to infection prior 
to symptoms. This gives promise for the development of a cost effective triage 
diagnostic that would optimize response to a disease epidemic or pandemic.  The next 
step in the research is to compare a second disease to the cowpox protein signature and 
confirm that selectivity is possible.   
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Appendix I. Class Prediction by Canonical Analysis
Denote the number of groups as h, the number of observations as N, and the 
number of variables as p. Divide the data set into a training set and a test set with 
observation numbers Nr and Ns, respectively, and N=Nr+Ns. To perform class 
prediction on a test set using canonical analysis, first form the between-group sum-of-
squares-and-cross-products matrix (SSCP), denoted by B, and the within-group SSCP 
W from the training-set data matrix. Then solve Be –lWe=0 for the eigenvalue l and 
the eigenvector e. There will be min(p, h–1) nonzero eigenvalues. The associated 
eigenvectors are the only ones we are concerned with. These eigenvectors map both the 
training set and test set observations to canonical space, i.e., the position of an 
observation on the axis defined by the ith eigenvector is yi=e
iT
xj where T denotes the 
transpose and xj denotes the vector in RBM protein measurements of a particular 
observation j. All the xj’s from a particular group in the training set are used to define 
the centroids (mean position of the kth group is mk) of the group in canonical space. 
Each xj from the test set is assigned membership in the group whose centroid is nearest 
to it in canonical space, i.e., y belongs to the kth group if ||y – mk|| is the minimum for 
||y-mi|| for all i.
In the backward elimination procedure, we begin with p proteins and eliminate the 
protein contributing the least to the discrimination. This continues successively until 
only one protein is left. At each stage we calculate the canonical analysis and assign 
membership of the test set observations. So at each stage we have the number of 
incorrect assignments for that number of proteins used in the canonical analysis.
Appendix II. 10-Fold External Cross Validation and Data Handling
Cross Validation
In an M-fold external cross validation, the data set is partitioned into M subsets of 
approximately equal size. Each subset is selected in turn as the test set, the remaining 
M–1 subsets are combined as the training set. Then the discrimination method is 
applied to the training set and any variable selection is carried out for that training set. 
After the discrimination function is constructed, we use the discrimination function to 
assign group membership to the observations in the test set. This procedure is repeated 
for all the M subsets. The distinction between an external cross validation and an 
internal cross validation is that in the former case variable selection occurs each time a 
discrimination function is constructed. In the latter case, variable selection is done only 
once at the outset and then the same variables are used for all construction of 
discrimination functions. Because the full data set is partitioned randomly into the M
subsets, one must perform the portioning many times to get a sense of the statistical 
variation in the error rate of group assignment. In the cases studied here, we performed 
1000 partitions. Ambroise and MacLachlan [15] have established the value of the 10-
fold external cross validation to estimate of the error rate.
